Colon cancer​ patients saw improved survival rates after a 3-year exercise program, according to a first-of-its-kind ...

The world’s largest meeting on cancer research has brought promising updates on treatment and prevention for colorectal ...

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...

Several oral abstracts presented at the American Society of Clinical Oncology’s annual meeting highlight ongoing research of Keytruda, Opdivo, Tecentriq and more in skin cancer.

Breast cancer study results impressed at this year’s meeting, but raised new questions. Doctors also wrestled with how best ...

Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without ...

Five early-career Fred Hutch/UW researchers received prestigious Young Investigator Awards from Conquer Cancer, the ASCO Foundation during this year's annual meeting of the American Society of ...

New hope is on the horizon in the fight against cancer. At this year’s American Society of Clinical Oncology (ASCO) annual ...

Researchers looked at more than 1,600 patients with stage 3 colon cancer. They found that those who ate the most ...

The Trump administration's proposed funding cuts to the National Institutes of Health (NIH), including the National Cancer ...

The first half of this year has been riddled with market volatility and geopolitical tension. But 2025’s American Society of ...

Oncology biosimilars significantly reduce financial toxicity in cancer care, as highlighted in 2 abstracts presented at the ...